Orexigen Therapeutics (NASDAQ: OREX) received the Day 180 List of Outstanding Issues (LOI) from the European Medicines Agency's Committee for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE